Journals / Göztepe Tıp Dergisi / 2011 / Cilt: 26 - Sayı: 3

Hair and systemic diseases

Sistemik hastalıklarda saç

Pages
128–132
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is beneficial to evaluate hair diseases with knowledge of hair structure besides clinical observation for associating systemic diseases with metabolic mechanisms and further researches.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hair disorders can be one of the manifestations of a multitude of systemic diseases.
📊
Key Findings & Data:Hair disorders may be subdivided into three categories: hair loss, excess of hair and variations in hair colour.
💡
Conclusion & Impact:It is beneficial to evaluate hair diseases with knowledge of hair structure besides clinical observation for associating systemic diseases with metabolic mechanisms and further researches.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hair disorders can be one of the manifestations of a multitude of systemic diseases. Hair disorders may be subdivided into three categories: hair loss, excess of hair and variations in hair colour. With many causes variying from hormonal diseases to aging, the hairloss as a title can be dividede into five main groups: anagen effluvium, telogen effluvium, destruction of hair follicles, miniaturization of hair follicles and hair shaft defects. Systemic diseases in which metabolic mechanisms mainly take role, are observed as colour changes in hair. Herein we discussed hair and hair conditions with related systemic diseases in groups. It is beneficial to evaluate hair diseases with knowledge of hair structure besides clinical observation for associating systemic diseases with metabolic mechanisms and further researches.

Özet

Saç bozuklukları birçok sistemik hastalığın bir göstergesi olabilir ve saç kaybı, saçlarda artma ve renk değişiklikleri olarak üçe ayrılabilir. Hormonal değişiklikten yaşlanmaya birçok faktörün etkili olduğu saç kaybını genel olarak beş ana grupta incelemekteyiz: anagen effluvium, telogen effluvium, saç foli-küllerinin yıkımı, saç foliküllerinin nıinyatürleşmesi ve saç şaftı defektleri. Saç rengi değişiklileri ise metabolik mekanizmaların devrede olduğu sistemik hastalıklarda gözlenir. Burada gruplar halinde saç hastalıkları ve ilişkili sistemik hastalıklar gözden geçirilip tartışılmıştır. Saç hastalıklarını saç yapı bulguları ve klinik görünümleri ile değerlendirmek, mevcut metabolik mekanizmalarla birlikte sistemik hastalıkları ilişkilendirmeyi ve ileriye yönelik araştırmaları kolaylaştırmaktadır.

🔖

Cite This Article

CAN, B., KAVALA, M., TÜRKOĞLU, Z. (2022). Hair and systemic diseases. Göztepe Tıp Dergisi, Cilt: 26 - Sayı: 3, 128–132. https://ajindex.com/articles/526122

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Sperling LC. Hair and systemic disease. Dermatol Clin 2001;19:711-726.
  2. Gathers RC, McMichael AJ. Hair disorders in systemic disease. Dermatologic Signs of Internal Disease. Ed. Callen J, Jorizzo J, Bolgnia JL, et al. 4. baskı. Elsevier, Saunders, 2003, 355-364
  3. Serdaroğlu S, Oğuz O. Saç hastalıkları. Dermatoloji.Ed. Tüzün Y, Giirer MA, Serdaroğlu S, Oğuz O, Aksungur VL. 3. baskı, istanbul, Nobel Tıp Kitabevi, 2008; 1295-1344
  4. Saitoh M, Uzuka M, Sakamoto M. Human hair cycle. J Invest Dermatol 1970;54:65-81. http://dx.doi.org/10.llll/1523-1747.epl2551679 PMid:5416680 5. Olsen EA. Hair. Fitzpatrick's Dermatology in General Medicine. Ed. Freedberg IM, Eisen AZ, Wolf K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB. 6. baskı. New York, Mc Graw-Hill, 2003; 633-655
  5. Almagro M, del Pozoj, Garcia-Silva J, et al. Telogen effluvium as a clinical presentation of human immunodeficiency virus infection. Am J Med 2002;112:508-509.
  6. Özdemir M. Telojen saç dökülmesi. Türkiye Klinikleri. J Int Med Sci 2006;2(31 ):6-9
  7. Sperling LC, Mezebish DS. Hair diseases. Med Clin North Am 1998;82:1155-1169.
  8. Springer K, Brown M, Stulberg DL. Common hair loss disorders. Am Fam Physician 2003;68:93-102. PMid: 12887115 10. Sperling LC, Lupton GP. Histopathology of non-scarring alopecia. J Cutan Pathol 1995;22: 97-114. http://dx.doi.org/10.1111/j. 1600-0560.1995. tbOl 391.x PMid:7560359 11. Sinclair R, Grossman KL, Kvedar JC. Anagen hair loss. Disorders of Hair Growth. Ed. Olsen EA. New York, Mc Graw Hill, 2003; 275-302
  9. Hunt S, Caserio R, Abell E. Primary systemic amyloidosis causing diffuse alopecia by telogen arrest. Arch Dermatol 1991;127:1067-1069. http://dx.doi.org/10.1001/archderm. 127.7.1067 PMid:2064414 13. Johnson W. Metastatic carcinoma of the skin. Lever's histopathology of the skin. Ed. Elder D, Elenitsas R, Javvorsky J, et al. 8.baskı. Philadelphia, Lippincot. Raven, 1997; 1011-1020
  10. Stroud JD. Hair-shaft anomalies. Dermatol Clin 1987;5:581-594. PMid:3301115 15. Berker DAR, Messenger AG, Sinclair RD. Disorders of hair. Rook's Textbook of Dermatology. Ed. Burns T, Breathnach S, Cox N, Griffiths C 7. Baskı. Oxford, Blackwell Science Ltd. 2004;63.1-63.120
  11. Dawber R, Neste DV. Hair and scalp disorders. 1. baskı. Philadelphia, JB. Lippincott Company 1995; 229-243
  12. Özpoyraz M, Acar A. Pigmentasyon bo